Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
Background: In the next 25 years, the epidemiology of cervical cancer in England, UK, will change: human papillomavirus (HPV) screening will be the primary test for cervical cancer. Additionally, the proportion of women screened regularly is decreasing and women who received the HPV vaccine are due...
Main Authors: | Alejandra Castanon, MD, Rebecca Landy, PhD, Francesca Pesola, PhD, Peter Windridge, PhD, Prof Peter Sasieni, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | The Lancet Public Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468266717302220 |
Similar Items
-
Global colorectal cancer burden in 2020 and projections to 2040
by: Yue Xi, et al.
Published: (2021-10-01) -
Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study
by: Helen C Johnson, MSc, et al.
Published: (2018-01-01) -
Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
by: Alejandra Castañón, et al.
Published: (2014-01-01) -
The effects and preventability of 2627 patient safety incidents related to health information technology failures: a retrospective analysis of 10 years of incident reporting in England and Wales
by: Guy Martin, PhD, et al.
Published: (2019-07-01) -
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
by: Marc Arbyn, PhD, et al.
Published: (2020-02-01)